January 2014 Newsletter

January 20, 2014:

IOL Industry Shows Modest Recovery in 2013

The market experienced revenue growth of 5.1 percent, driven mainly by premium lenses.

January 20, 2014:

Ophthalmic Ventures Raised Record $763.7 Million for Product Development Efforts in 2013

This amount compares with $215 million in 2012 and $350 million in 2011.

January 20, 2014:

Refractive Industry Awaits Better Economic Times

Global demand for refractive surgery continued to suffer in 2013 from a combination of economic malaise and bad press regarding the risks of LASIK.

January 20, 2014:

Micro-gauge Options Expand in Retinal, Glaucoma Markets

A growing number and variety of instruments were offered.

January 20, 2014:

2013 Pharma Market Waiting for the Next Big Advances

In the retinal pharma market, 2013 brought signs of a maturing anti-VEGF market sector; in the glaucoma pharma market, generic medications continued to significantly affect revenue.

January 20, 2014:

US Regulatory Approvals Bring Key Products and Generics

US regulators were busy in 2013 with a host of approvals for new products, supplemental labeling, and generic versions of drugs.

January 20, 2014:

Valeant’s Purchase of Bausch + Lomb Headlines Ophthalmic Acquisitions

The $8.7 billion acquisition accounted for an estimated 87 percent of all acquisition funds in the ophthalmic market in 2013.

January 20, 2014:

As Generics Depress Revenues in Glaucoma Pharma Market, Emerging Economies Will Drive Most Growth

The market currently generates roughly $4.2 billion in annual revenue at the manufacturer’s level.

January 20, 2014:

Photocoagulation, SLT, and YAG Lasers Play a Key Role in Ophthalmic Market

We forecast global revenues for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT devices—along with maintenance, accessories, and endoprobes, to total $380 million in 2013.

January 20, 2014:

House, Senate Committees Approve Bills to Repeal SGR

The bills are expected to be taken up by the full House and Senate in the coming weeks.

January 20, 2014:

Carl Zeiss Meditec Acquires Aaren Scientific

Deal was for $70 million in cash.

January 20, 2014:

Drugmakers’ Influence on Doctors Under Fire

Drugmakers' influence on doctors made headlines recently in two cases involving companies that market to ophthalmologists.

January 20, 2014:

January 2014 News Briefs

Social media